| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.48 | 4e-21 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.4 | 8e-16 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-15 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.44 | 1e-12 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-10 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |